Sunesis Pharmaceuticals, Inc.
(NASDAQ CM: SNSS)
Rigrodsky Law, P.A. is investigating Sunesis Pharmaceuticals, Inc. (“Sunesis”) regarding possible breaches of fiduciary duties and other violations of law related to Sunesis' agreement to merge with Viracta Therapeutics, Inc. ("Viracta"). Under the terms of the agreement, Sunesis will issue a number of shares of Sunesis common stock to stockholders of Viracta.